**Introduction:** We present a patient with systemic lupus erythematosus who has had two very different experiences of pregnancy. The first was associated with poorly controlled disease and considerable morbidity for the patient and baby. The second was planned in conjunction with the combined rheumatology and obstetrics clinic and was associated with well controlled lupus and good outcomes for mother and child.

**Case description:** Our patient, a nineteen year old lady in the twentieth week of her first pregnancy, presented with a two month history of malaise, arthralgia and myalgia, facial and orbital swelling. There was no history of previous medical problems nor of miscarriages. On examination, she had a swinging pyrexia to 38.5 degrees centigrade, facial oedema and a malar rash. There was no synovitis. There was reduced air entry at the left lung base, and oedema to the mid-thighs and sacrum. Initial investigations showed her to have a haemoglobin of 77 g/L (110-147), and lymphocyte count of 0.43x109/L (1-3x109/L). Renal function was normal, but liver function was deranged: alkaline phosphatase (ALP) 265 IU/L (30-130), alanine transaminase (ALT) 51 IU/L (0-33), aspartate transaminase (AST) 211 IU/L (0-32), gamma-glutamyl transpeptidase (GGT) 287 IU/L (0-40). C-reactive protein was 48 mg/L (0-5). A chest radiograph showed a left pleural effusion. She was initially treated with cefuroxime for a presumed chest infection. Further investigations showed her to be anti-nuclear antibody (ANA) positive with a homogeneous pattern, anti-Ro antibody positive, double stranded DNA antibody (dsDNA) positive at greater than 500 IU (0-60), and crithedia positive. Complement levels were low: C3 0.34 g/L (0.75-1.65) and C4 0.14 g/L (0.14-0.54). A Coombs test was positive. Anti-cardiolipin IgG antibodies were raised at 59 units (0-8), but lupus anticoagulant and anti-beta II glycoprotein 1 antibodies were negative. Twenty four hour urinary protein levels were 5.26 g (0.01-0.15). An echocardiogram showed her to have a small, posterior pericardial effusion. She was diagnosed with systemic lupus erythematosus, with haemolytic anaemia and nephrotic syndrome, and was commenced on 20mg prednisolone daily. There was an initial improvement in symptoms, but after three days she became increasingly short of breath with chest pains and palpitations. An electrocardiogram (ECG) showed atrial fibrillation at a rate of 170 beats per minute, thought to be secondary to serositis. She reverted to sinus rhythm with digoxin. A computerised tomography pulmonary angiography scan (CTPA) showed no evidence of pulmonary embolism. Prednisolone was increased to 60mg daily and aspirin 75mg daily was commenced. The patient's symptoms gradually improved and after two weeks she was discharged on 40mg prednisolone daily. Azathioprine was started at twenty-seven weeks. At twenty-eight weeks, our patient presented with headaches and blurred vision. She was found to be hypertensive and to have three pluses of blood and four pluses of protein in her urine. Atenolol was commenced. At thirty-one weeks, our patient was admitted with abdominal pain and vaginal bleeding. Haemoglobin was 85 g/L and lymphocytes 0.58x109/L. Renal and liver function were normal. Blood pressure was 133/81 mmHg. dsDNA was still strongly positive at 494 IU. C3 was 0.7 g/L and C4 0.17 g/L. Twenty four hour urinary protein was 6.89 g. She was found to have a placental abruption and went into spontaneous labour. She delivered a female baby weighing 1800 g who was looked after on the special care baby unit for her first six weeks. She had initial respiratory distress syndrome, jaundice and anaemia. She had a patent ductus arteriosus which subsequently resolved, bilateral subependymal haemorrhages which also resolved, and a coagulase negative staphylococcus sepsis related to her long line. The child has since made normal progress. Post-partum our patient continued to improve on azathioprine, a reducing dose of prednisolone, aspirin and atenolol. Three weeks post-partum, twenty-four hour urinary protein was 2.94 g, and by three months it was 1.04 g. Blood pressure normalised and atenolol was stopped. Prednisolone was down to 10mg daily. Six months later, there was an increase in lupus activity with fatigue, arthritis and shortness of breath. There was a neutropenia, a rise in the dsDNA and a fall in C3. There were three pluses of protein in the urine. Prednisolone was increased back to 30mg daily and azathioprine was switched to mycophenolate mofetil. Our patient improved, and for the first time since her presentation there was no evidence of protein in the urine. Two years later, our patient advised us that she was contemplating a second pregnancy. She had had good control of her lupus for twelve months. Blood pressure was 110/60 mmHg and there was no proteinuria. Haemoglobin was 127 g/L, lymphocytes 0.9x109/L. Renal and liver function were normal. ANA was positive (coarse speckled pattern) and anti-Ro was positive. dsDNA was 41 IU, C3 0.97 g/L and C4 0.16 g/L. She was referred to the combined rheumatology and obstetrics clinic for pre-conception counselling. She was advised to discontinue mycophenolate and to restart azathioprine. She was informed that she would have better outcomes in terms of lupus and pregnancy if her disease was stable at the time of conception. She was established on azathioprine with no deterioration in her lupus, and therefore she was encouraged to start trying for a second child. She was closely monitored in the combined clinic through her second pregnancy. At twelve weeks she developed some joint pain and swelling, and serology suggested her lupus was becoming active. Prednisolone was increased from 7.5mg to 15mg daily. She responded and stayed well through the rest of her pregnancy. She went into spontaneous labour at thirty-nine weeks and delivered a healthy female weighing 3838 g.

**Discussion:** This case is interesting because it shows the very different experiences that a woman can have during pregnancy with systemic lupus erythematosus. With new, poorly controlled disease there was considerable morbidity for mother and child. With established and well controlled disease the pregnancy progressed smoothly. The case highlights the importance of planned and monitored pregnancies in patients with systemic lupus erythematosus, and emphasises the pivotal role that a combined rheumatology and obstetrics clinic plays in achieving this.

**Key learning points:** SLE can present de novo in pregnancy and can be difficult to gain control of. Poorly controlled disease is associated with high maternal risk, including hypertension, pre-eclampsia and placental abruption, and high foetal risk, including prematurity. Maternal and foetal outcomes are best when lupus is quiescent prior to conception. Close liaison between patient, rheumatologist and obstetrician is vital to help ensure a planned and safe pregnancy.
